Release date: 2014-11-05
According to a new study at the National Cancer Institute (NCRI) Cancer Conference in Liverpool, scientists have identified more than 800 markers in the blood of cancer patients, which may help future research and development for all types of cancer. Blood test for early detection.
This is the first comprehensive review and identification of cancer-related blood markers that will facilitate future clinical development. The study, conducted by the Early British Cancer Society, analyzed more than 19,000 research articles and found more than 800 biomarkers, which were funded by the UK's cancer research.
The goal of this study was to develop a screening test that would identify multiple cancer types using a single blood sample. All cancers produce markers in the blood, so developing universal screening tests for many different disease forms is feasible.
The survival rate of cancer in the UK is lower than in some other Western countries, partly due to the late diagnosis. But developing more ways to detect cancer early, including researching new screening techniques, as suggested by this latest study, may provide more options for rickets and save more patients in the future.
After the detection of cancer in the UK is almost always after the patient has shown certain symptoms, only a small percentage of the cancer is detected by one of the three national screening programs for breast, colon and cervical cancer. The study opens up the possibility of new invasive screening tests that will detect more cancer types at an earlier stage, even including some rare types, giving patients the opportunity to receive treatment.
British Cancer Research is committed to the early diagnosis of cancer and, more importantly, to reducing late diagnosis and improving long-term survival. Research author, British Cancer Research Funded Scientist, Coventry University Hospital and Ian of Warwick University? Professor Ian Cree said: “This is a new approach to early detection and the first comprehensive review of such a system. A single blood screening test will revolutionize early detection of cancer or may help cure more cancer patients. I believe we have identified all relevant biomarkers; the next step is to find out which markers are the best candidates for cancer detection."
The identified biomarkers will be reviewed and classified, and then further developed in clinical laboratory studies. Sarah, director of early diagnosis of cancer research in the UK? “This is an innovative and promising new approach,†said Sara Hiom. “Although still at an early stage, it has shown that our growing understanding of cancer markers and the combination of emerging technologies will be early. Detecting cancer offers new opportunities. Early diagnosis of cancer means more effective treatments, which means higher survival rates. Our goal for the next 20 years is to have at least 3/4 of patients diagnosed with cancer at least I can live for 10 years."
Source: Phoenix Technology
Adult Non-Woven Fabrics Cover,Bacteria Protection Face Mask,3-layer Filter Protective Face Mask
Dongguan Keyutai Mask Co., Ltd. , https://www.maskkytai.com